Current News
-
Anti-medical school, pro health
Medical schools teach what is known in medicine, explains BioE associate professor Steve Conolly, who helped bring Anti-Medical School to Berkeley from UCSF this year. The QB3-inspired course explores what is unknown and unsolved in medicine, and that’s what 70 students, mainly first- and second-year bioengineering graduate students, found compelling. (read more)
-
Mofrad Receives NSF CAREER Award
Berkeley Bioengineering professor Mohammad Mofrad, a QB3 member, has received a 2010 National Science Foundation Faculty Early Career Development (CAREER) Program award. CAREER awards are given to young researchers in science and engineering who have also translated their work into significant education activities. (read more)
-
Engineers develop cancer-targeting nanoprobe sensors
QB3 scientists at UC Berkeley have created smart nanoprobes that may one day be used in the battle against cancer to selectively seek out and destroy tumor cells, as well as report back on the mission's status. (read more)
Hot Topics
-
UCSF creates unifying program in quantitative biosciences
UCSF has created an umbrella program in quantitative biosciences that will help raise the university's profile as a destination for top graduate students. The program, the Quantitative Biosciences Consortium (QBC), brings together existing graduate programs in biophysics, bioengineering, chemistry and chemical biology, pharmaceutical sciences and pharmacogenomics, complex biological systems, and biological informatics. (read more)
-
Secrets of NIH SBIR and STTR grant applications
If you missed Dr. Gregory Milman's January 13 talk "The Secrets of NIH SBIR and STTR Grant Applications," his slides are now available for download. (read more)
-
QB3/GE bioprocessing course
The QB3/GE bioprocessing course concluded on January 29. This extensive introduction to the separation and purification of proteins, antibodies, and DNA is offered every six months. The next course will be held at UC Berkeley in June. (read more)
